Ye et al. demonstrated that both the expression of neutrophil-derived lipocalin 2 (LCN2) and the chemokine CXCR2 were significantly elevated in mouse models and human patients with NAFLD. This evidence concerns the gene CXCR2 and metabolic dysfunction-associated steatotic liver disease.